Attached files
file | filename |
---|---|
EX-31.1 - CERTIFICATION - LA JOLLA PHARMACEUTICAL CO | exhibit311.htm |
EX-32.1 - CERTIFICATION - LA JOLLA PHARMACEUTICAL CO | exhibit321.htm |
EX-31.2 - CERTIFICATION - LA JOLLA PHARMACEUTICAL CO | exhibit312.htm |
EX-21.1 - SUBSIDIARIES OF LA JOLLA PHARMACEUTICAL COMPANY - LA JOLLA PHARMACEUTICAL CO | exhibit211.htm |
EX-10.22 - EMPLOYMENT OFFER LETTER LAKHMIR CHAWLA - LA JOLLA PHARMACEUTICAL CO | exhibit1022.htm |
10-K - 10-K - LA JOLLA PHARMACEUTICAL CO | ljpc-20151231x10k.htm |
EX-10.24 - UPDATED EMPLOYMENT OFFER LETTER JENNIFER ANNE CARVER - LA JOLLA PHARMACEUTICAL CO | exhibit1024.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements (No. 333-206855) on Form S-3 and (No. 333-207212) on Form S-8 of La Jolla Pharmaceutical Company of our report dated February 25, 2016, relating to our audits of the consolidated financial statements and internal control over financial reporting, which appear in this Annual Report on
Form 10-K of La Jolla Pharmaceutical Company for the year ended December 31, 2015.
/s/ SQUAR MILNER LLP
(formerly Squar, Milner, Peterson, Miranda & Williamson, LLP)
San Diego California
February 25, 2016